Bellur S. Prabhakar

Affiliations: 
Microbiology and Immunology University of Illinois at Chicago, Chicago, IL, United States 
Area:
Immunology, Microbiology Biology
Google:
"Bellur Prabhakar"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kumar P, Balakrishnan S, Surendra Lele S, et al. (2022) Restoration of Follicular T-Regulatory/Helper Cell Balance by OX40L-JAG1 Cotreatment Suppresses Lupus Nephritis in NZBWF1/j Mice. Journal of Immunology (Baltimore, Md. : 1950)
Kumar P, Arbieva ZH, Maienschein-Cline M, et al. (2021) Induction of Antigen-Independent Proliferation of Regulatory T-Cells by TNF Superfamily Ligands OX40L and GITRL. Methods in Molecular Biology (Clifton, N.J.). 2248: 63-71
Balakrishnan S, Kumar P, Prabhakar BS. (2020) Post-translational modifications contribute to neoepitopes in Type-1 diabetes: Challenges for inducing antigen-specific tolerance. Biochimica Et Biophysica Acta. Proteins and Proteomics. 1868: 140478
Dai S, Lv Y, Xu W, et al. (2020) Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice. Cancer Gene Therapy
Kumar P, Lele SS, Ragothaman VK, et al. (2019) OX40L-JAG1-Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB Signaling. Journal of Immunology (Baltimore, Md. : 1950)
Seth P, Yang Y, Xu W, et al. (2019) An oncolytic adenovirus targeting TGFβ inhibits pro-tumorigenic signals and produces immune activation: A novel approach to enhance anti-PD-1 and anti-CTLA-4 therapy. Human Gene Therapy
Saini S, Sripada L, Tulla K, et al. (2019) MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer. Endocrine-Related Cancer. 26: 551-563
Saini S, Sripada L, Tulla K, et al. (2019) Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer. Cell Death & Disease. 10: 145
Kumar P, Saini S, Prabhakar BS. (2019) Cancer Immunotherapy with Check Point Inhibitor Can Cause Autoimmune Adverse Events Due to Loss of Treg homeostasis. Seminars in Cancer Biology
Kumar P, Saini S, Khan S, et al. (2018) Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells. Cellular Immunology
See more...